Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Janssen
 More »

  • AstraZeneca, Janssen to Promote Novel Prostate Cancer Treatment...
    with Janssen Pharmaceuticals K.K. in Japan to co-promote abiraterone acetate, an oral therapy for the treatment of patients with prostate cancer. Janssen Pharmaceuticals ...
    10-11-2013
  • J&J Innovation, Janssen, and Joslin Diabetes to Pump Up Exercise...
    & Johnson Innovation and its affiliate Janssen Research & Development with the aim of ... with Johnson & Johnson Innovation and Janssen Research & Development is an excellent ...
    10-10-2013
  • Active Biotech and Hutchison China MediTech Get Rewarded
    Hutchison MediPharma Limited earned its $6 million payment from Janssen for the ... entitled to royalties on worldwide sales upon commercialization of a product by Janssen. ...
    10-9-2013
  • J&J's Janssen Buys Rights to Hepatitis C Compound from GSK
    Johnson & Johnson's Janssen Pharmaceuticals unit said today it acquired GSK2336805, an ... The price was not disclosed. Janssen said it acquired from GSK all rights to develop and ...
    10-8-2013
  • J&J's Janssen Companies Launch a Trio of Collaborations
    The Janssen Pharmaceutical Companies of Johnson & Johnson had itself a very busy day ... Janssen Biotech won an exclusive option to develop Effimune's drug candidate FR104, a ...
    10-3-2013
  • FDA Speeds Things Up
    ... are getting meetings very quickly with the FDA," said Peter Lebowitz, global oncology therapeutic area head with J&J's Janssen division. "FDA is working with us to solve issues." ...
    10-1-2013
  • PATH Evaluates Janssen's Rilpivirine as HIV Infection Prophylactic
    Janssen R&D Ireland has signed a license agreement with PATH to develop an injectable form ... Currently, it is commercialized by Janssen for the oral, once daily treatment of HIV-1, in ...
    9-25-2013
  • Medivir, Daewoong Discontinue HBV Drug Development
    results of its key pipeline asset simeprevir, a protease inhibitor in late Phase III development for hepatitis C that is being developed in collaboration with Janssen R&D Ireland. ...
    9-6-2013
  • Otsuka Acquires Astex for $866M
    Dacogen, now marketed by Eisai in North America and by Janssen elsewhere, generates about $280 million in worldwide annual sales. Last month Astex reported promising results for a ...
    9-5-2013
  • FDA Speeds Things Up
    ... are getting meetings very quickly with the FDA," said Peter Lebowitz, global oncology therapeutic area head with J&J's Janssen division. "FDA is working with us to solve issues." ...
    9-3-2013
  • Ligand, CURx Make $21M Injectable Epilepsy Drug Deal
    Captisol® is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Topiramate is sold by Janssen Pharmaceuticals under ...
    8-14-2013
  • Amunix, Janssen Expand XTEN Collaboration
    with Johnson & Johnson's Janssen Biotech unit will expand now that an option has been exercised for the development of an additional therapeutic molecule that Janssen will select. ...
    8-14-2013
  • Big Need in IBD: Drugs to Slow Progression
    ... Janssen also is recruiting patients for a Phase IV multicenter, prospective, long-term, ... Study completion is set for December 2035. Meanwhile, Janssen is recruiting participants ...
    8-1-2013
  • Sigma-Aldrich Partners with Scripps in Reagents R&D
    ... TSRI inked five-year collaborations with Johnson & Johnson's Janssen Pharmaceuticals unit ... which misidentified the collaboration partner of Janssen and BMS. GEN regrets the error. ...
    7-18-2013
  • Royalty Pharma Buys Quest Cancer Candidate Royalty Rights for...
    Quest gained rights to royalties on ibrutinib-a Bruton's tyrosine kinase inhibitor currently in in Phase III development by Pharmacyclics and Janssen-as part of its 2011 ...
    7-18-2013

  • Journal Articles

  • The Scientific Observatories on Mont Blanc
    Jean-Paul Richalet
    High Altitude Medicine & Biology
    While Jules Janssen and Xaver Imfeld were preparing the construction of the new observatory on the top of Mont Blanc, Dr. Jacottet died in 1891 at the Observatoire Vallot from a ...
  • Efficacy of Arnica montana D4 for Healing of Wounds After Hallux...
    Jens-Hagen Karow, Hans-Peter Abt, Markus Fröhling, Hanns Ackermann
    Journal of Alternative and Complementary Medicine, The
    No significant differences were found regarding the use of additional analgesics during the 4 postoperative days (Dipidolor,® Janssen-Cilag, Neuss, Germany; p = 0.54; Tramal,® ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll